Intravenous Pantoloc In Aspirin-Induced Ulcer Bleeding

• Status: Completed
• Trial end date: 2006-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of the study is to investigate whether intravenous infusion of pantoprazole (Pantoloc) is effective in preventing recurrent bleeding in patients who present with acute ulcer bleeding and continue to use aspirin

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Chinese University of Hong Kong
• Treatments: Aspirin

Criteria

Inclusion Criteria:

• Patients received daily anti-platelet therapy for vascular prophylaxis before admission and will continue need to do so

• Patinets with bleeding peptic ulcers;ulcer actively bleeding or with SRH (Forrest I, IIa and IIb ulcers)

• Endoscopic haemostasis achieved

Exclusion Criteria:

• Presence of ulcer complication precluding endoscopic treatment such as gastric outlet obstruction or ulcer perforation mandating surgical intervention.

• Concomitant use of anticoagulant, NSAIDs or steroid

• Pending to undergo cardiac interventions that need double anti-platelet agent

• Pregnancy

• Terminal illness, or cancer